Contact Us

PACLITAXEL

Category :
Ovarian carcinoma 
  • First-line therapy in combination with a platinum compound for the treatment of advanced metastatic carcinoma of the ovary. 
  • Second-line therapy for the treatment of advanced metastatic carcinoma of the ovary.

 

Breast carcinoma 
  • Adjuvant treatment of node-positive breast cancer administered sequentially to standard combination therapy. 
  • Therapy after relapse within 6 months of adjuvant therapy. Prior therapy should have included an anthracycline unless clinically contraindicated. 
  • Second-line therapy after failure of combination chemotherapy for metastatic disease. Prior therapy should have included an anthracycline unless clinically contraindicated. 
  • For the treatment of advanced or metastatic breast cancer in combination with trastuzumab in patients who over express HER-2 at 3+ level as determined by immunohistochemistry or FISH +.

 

Non-small cell lung carcinoma (NSCLC) 

First-line therapy in combination with a platinum compound for the treatment of non-small cell carcinoma of the lung in patients who are not candidates for potentially curative surgery and / or radiation therapy.

 

Kaposi’s sarcoma 

 

Second-line treatment of AIDS-related Kaposi’s sarcoma

 

Compositions :

Each mL contain Paclitaxel 6 mg

 

Storage Condition

Store below 30°C

 

Shelf Life :
Tag :

Other Products

NESBELL
Read More
DOCETAXEL
Read More
BELOTAXEL
Read More
GEMTAN
Read More

Need More Information?

Contact CKD OTTO Pharma now for more information about our products and services.

Scroll to Top